The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 14 results:
[ Author(Desc)] Title Type Year
Filters: Author is Sinakos, Emmanouil  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sinakos, E., Dedes I., Papalavrentios L., Drevelegas A., & Akriviadis E. (2010).  Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.. Scand J Gastroenterol. 45(4), 511-2.
Sinakos, E., & Lindor K. (2010).  Treatment options for primary sclerosing cholangitis.. Expert Rev Gastroenterol Hepatol. 4(4), 473-88.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Sinakos, E., Samuel S., Enders F., Loftus E. V., Sandborn W. J., & Lindor K. D. (2013).  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.. Inflamm Bowel Dis. 19(5), 1004-9.
Sinakos, E., Marschall H-U., Kowdley K. V., Befeler A., Keach J., & Lindor K. (2010).  Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.. Hepatology. 52(1), 197-203.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Sinakos, E., Abbas G., Jorgensen R. A., & Lindor K. D. (2012).  Serum lipids in primary sclerosing cholangitis.. Dig Liver Dis. 44(1), 44-8.
Sinakos, E., & Lindor K. D. (2010).  Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?. Am J Gastroenterol. 105(3), 596-8.
Sinakos, E., Vlachaki E., & Tsapas A. (2012).  Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.. Br J Haematol. 157(4), 505-6; author reply 506-7.
Sinakos, E., Saenger A. K., Keach J., W Kim R., & Lindor K. D. (2011).  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.. Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
Sinakos, E., Hytiroglou P., Stachteas P., Liava C., & Akriviadis E. (2019).  The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis.. Eur J Gastroenterol Hepatol. 31(7), 897-898.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Sinakos, E., Selvaggi G., Papalavrentios L., Tzakis A., & Akriviadis E. (2011).  The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence.. Ann Gastroenterol. 24(3), 228-230.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.